News headlines about Nanosphere (NASDAQ:NSPH) have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Nanosphere earned a coverage optimism score of 0.01 on Accern’s scale. Accern also assigned news headlines about the medical research company an impact score of 46.1269214546221 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Shares of Nanosphere (NSPH) traded down $0.01 during midday trading on Wednesday, reaching $1.69. The company’s stock had a trading volume of 186,100 shares, compared to its average volume of 886,293. Nanosphere has a fifty-two week low of $0.48 and a fifty-two week high of $3.64.
Nanosphere, Inc is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing.
What are top analysts saying about Nanosphere Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nanosphere Inc. and related companies.